{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T08:37:18Z","timestamp":1792831038496,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s00535-026-02489-z","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T02:48:27Z","timestamp":1785379707000},"page":"1620-1631","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Real-world efficacy and safety of avatrombopag in Japanese patients with chronic liver disease and severe thrombocytopenia"],"prefix":"10.1007","volume":"61","author":[{"given":"Yosuke","family":"Otsuka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9600-7407","authenticated-orcid":false,"given":"Naoki","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Kakizaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Ikegami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunji","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Majima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeharu","family":"Asano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihito","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiro","family":"Kamoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Hatanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Takakusagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Nihei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuko","family":"Soeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoyuki","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidekazu","family":"Kurata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayoshi","family":"Suga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Tahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rie","family":"Goka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamiko","family":"Tsukui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouichi","family":"Miura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomonori","family":"Yano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Mochida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Liver Investigators in Northern Kanto Study (LINKS) Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,30]]},"reference":[{"issue":"11","key":"2489_CR1","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1055\/a-1939-4887","volume":"54","author":"IM Gralnek","year":"2022","unstructured":"Gralnek IM, Camus Duboc M, Garcia-Pagan JC, et al. Endoscopic diagnosis and management of esophagogastric variceal hemorrhage: ESGE Guideline. Endoscopy. 2022;54(11):1094\u2013120.","journal-title":"Endoscopy"},{"issue":"1","key":"2489_CR2","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","volume":"69","author":"European Association for the Study of the Liver","year":"2018","unstructured":"European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69(1):182\u2013236.","journal-title":"J Hepatol"},{"issue":"9","key":"2489_CR3","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.4254\/wjh.v16.i9.1229","volume":"16","author":"OM Fierro-Angulo","year":"2024","unstructured":"Fierro-Angulo OM, Gonz\u00e1lez-Regueiro JA, Pereira-Garc\u00eda A, et al. Hematological abnormalities in liver cirrhosis. World J Hepatol. 2024;16(9):1229\u201344.","journal-title":"World J Hepatol"},{"issue":"6","key":"2489_CR4","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1111\/liv.13317","volume":"37","author":"M Peck-Radosavljevic","year":"2017","unstructured":"Peck-Radosavljevic M. Thrombocytopenia in chronic liver disease. Liver Int. 2017;37(6):778\u201393.","journal-title":"Liver Int"},{"issue":"3","key":"2489_CR5","doi-asserted-by":"publisher","first-page":"205","DOI":"10.7326\/M14-1589","volume":"162","author":"RM Kaufman","year":"2015","unstructured":"Kaufman RM, Djulbegovic B, Gernsheimer T, et al. Platelet transfusion: a clinical practice guideline from the AABB. Ann Intern Med. 2015;162(3):205\u201313.","journal-title":"Ann Intern Med"},{"issue":"3","key":"2489_CR6","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/bjh.14423","volume":"176","author":"LJ Estcourt","year":"2017","unstructured":"Estcourt LJ, Birchall J, Allard S, et al. Guidelines for the use of platelet transfusions. Br J Haematol. 2017;176(3):365\u201394.","journal-title":"Br J Haematol"},{"issue":"5","key":"2489_CR7","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1053\/j.gastro.2021.09.004","volume":"161","author":"NM Intagliata","year":"2021","unstructured":"Intagliata NM, Davitkov P, Allen AM, et al. AGA technical review on coagulation in cirrhosis. Gastroenterology. 2021;161(5):1630\u201356.","journal-title":"Gastroenterology"},{"issue":"Suppl","key":"2489_CR8","doi-asserted-by":"publisher","first-page":"S205","DOI":"10.3350\/cmh.2024.0928","volume":"31","author":"A Riescher-Tuczkiewicz","year":"2025","unstructured":"Riescher-Tuczkiewicz A, Rautou PE. Prediction and prevention of post-procedural bleedings in patients with cirrhosis. Clin Mol Hepatol. 2025;31(Suppl):S205\u201327.","journal-title":"Clin Mol Hepatol"},{"issue":"1","key":"2489_CR9","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s12325-021-01965-7","volume":"39","author":"M Yoshida","year":"2022","unstructured":"Yoshida M, Tateishi R, Hiroi S, et al. Effects of lusutrombopag on post-invasive procedural bleeding in thrombocytopenic patients with chronic liver disease. Adv Ther. 2022;39(1):379\u201390.","journal-title":"Adv Ther"},{"issue":"6","key":"2489_CR10","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.cgh.2018.11.047","volume":"17","author":"H Hidaka","year":"2019","unstructured":"Hidaka H, Kurosaki M, Tanaka H, et al. Lusutrombopag reduces need for platelet transfusion in patients with thrombocytopenia undergoing invasive procedures. Clin Gastroenterol Hepatol. 2019;17(6):1192\u2013200.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"2489_CR11","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00535-018-1499-2","volume":"54","author":"R Tateishi","year":"2019","unstructured":"Tateishi R, Seike M, Kudo M, et al. A randomized controlled trial of lusutrombopag in Japanese patients with chronic liver disease undergoing radiofrequency ablation. J Gastroenterol. 2019;54(2):171\u201381.","journal-title":"J Gastroenterol"},{"issue":"10","key":"2489_CR12","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1111\/hepr.13544","volume":"50","author":"K Numata","year":"2020","unstructured":"Numata K, Tanaka K, Katsube T, et al. Is platelet monitoring during 7-day lusutrombopag treatment necessary in chronic liver disease patients with thrombocytopenia undergoing planned invasive procedures? A phase IIIb open-label study. Hepatol Res. 2020;50(10):1141\u201350.","journal-title":"Hepatol Res"},{"issue":"11","key":"2489_CR13","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1007\/s40265-018-0949-8","volume":"78","author":"M Shirley","year":"2018","unstructured":"Shirley M. Avatrombopag: first global approval. Drugs. 2018;78(11):1163\u20138.","journal-title":"Drugs"},{"issue":"3","key":"2489_CR14","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1053\/j.gastro.2018.05.025","volume":"155","author":"N Terrault","year":"2018","unstructured":"Terrault N, Chen YC, Izumi N, et al. Avatrombopag before procedures reduces need for platelet transfusion in patients with chronic liver disease and thrombocytopenia. Gastroenterology. 2018;155(3):705\u201318.","journal-title":"Gastroenterology"},{"key":"2489_CR15","doi-asserted-by":"publisher","first-page":"5421632","DOI":"10.1155\/2020\/5421632","volume":"2020","author":"F Poordad","year":"2020","unstructured":"Poordad F, Terrault NA, Alkhouri N, et al. Avatrombopag, an alternate treatment option to reduce platelet transfusions in patients with thrombocytopenia and chronic liver disease-integrated analyses of 2 phase 3 studies. Int J Hepatol. 2020;2020:5421632.","journal-title":"Int J Hepatol"},{"issue":"4","key":"2489_CR16","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/hepr.13755","volume":"52","author":"Y Eguchi","year":"2022","unstructured":"Eguchi Y, Takahashi H, Mappa S, et al. Phase 2 study of avatrombopag in Japanese patients with chronic liver disease and thrombocytopenia. Hepatol Res. 2022;52(4):371\u201380.","journal-title":"Hepatol Res"},{"issue":"6","key":"2489_CR17","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.21178","volume":"43","author":"RK Sterling","year":"2006","unstructured":"Sterling RK, Lissen E, Clumeck N, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology. 2006;43(6):1317\u201325.","journal-title":"Hepatology"},{"issue":"4","key":"2489_CR18","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1159\/000479984","volume":"6","author":"A Hiraoka","year":"2017","unstructured":"Hiraoka A, Michitaka K, Kumada T, et al. Validation and potential of albumin-bilirubin grade and prognostication in a nationwide survey of 46,681 hepatocellular carcinoma patients in Japan: the need for a more detailed evaluation of hepatic function. Liver Cancer. 2017;6(4):325\u201336.","journal-title":"Liver Cancer"},{"key":"2489_CR19","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","volume":"3","author":"WJ Youden","year":"1950","unstructured":"Youden WJ. Index for rating diagnostic tests. Cancer. 1950;3:32\u20135.","journal-title":"Cancer"},{"key":"2489_CR20","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics. Bone Marrow Transplant. 2013;48:452\u20138.","journal-title":"Bone Marrow Transplant"},{"issue":"40","key":"2489_CR21","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000035208","volume":"102","author":"SK Satapathy","year":"2023","unstructured":"Satapathy SK, Sundaram V, Shiffman ML, et al. Real-world use of avatrombopag in patients with chronic liver disease and thrombocytopenia undergoing a procedure. Medicine (Baltimore). 2023;102(40):e35208.","journal-title":"Medicine (Baltimore)"},{"key":"2489_CR22","first-page":"1","volume":"36","author":"CD Fryar","year":"2021","unstructured":"Fryar CD, Carroll MD, Gu Q, et al. Anthropometric reference data for children and adults: United States, 2015\u20132018. Vital Health Stat 3. 2021;36:1\u201344.","journal-title":"Vital Health Stat 3"},{"issue":"1","key":"2489_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12937-023-00896-z","volume":"22","author":"D Watanabe","year":"2016","unstructured":"Watanabe D, Inoue Y, Miyachi M. Distribution of water turnover by sex and age as estimated by prediction equation in Japanese adolescents and adults: the 2016 National Health and Nutrition Survey, Japan. Nutr J. 2016;22(1):64.","journal-title":"Nutr J"},{"issue":"7","key":"2489_CR24","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1111\/j.1572-0241.1999.01231.x","volume":"94","author":"T Kawasaki","year":"1999","unstructured":"Kawasaki T, Takeshita A, Souda K, et al. Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis. Am J Gastroenterol. 1999;94(7):1918\u201322.","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"2489_CR25","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/cld.860","volume":"14","author":"AH Moore","year":"2019","unstructured":"Moore AH. Thrombocytopenia in cirrhosis: a review of pathophysiology and management options. Clin Liver Dis. 2019;14(5):183\u20136.","journal-title":"Clin Liver Dis"},{"issue":"1","key":"2489_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-020-01573-9","volume":"20","author":"H Nomoto","year":"2020","unstructured":"Nomoto H, Morimoto N, Miura K, et al. Lusutrombopag is effective and safe in patients with chronic liver disease and severe thrombocytopenia: a multicenter retrospective study. BMC Gastroenterol. 2020;20(1):427.","journal-title":"BMC Gastroenterol"},{"key":"2489_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/jgh3.70081","volume":"9","author":"T Suga","year":"2025","unstructured":"Suga T, Kakizaki S, Naganuma A, et al. Evaluation of the efficacy of lusutrombopag for chronic liver disease based on pre-treatment platelet counts: a retrospective multicenter study. JGH Open. 2025;9:e70081.","journal-title":"JGH Open"},{"key":"2489_CR28","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1056\/NEJMoa1110709","volume":"367","author":"NH Afdhal","year":"2012","unstructured":"Afdhal NH, Giannini EG, Tayyab G, et al. Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia. N Engl J Med. 2012;367:716\u201324.","journal-title":"N Engl J Med"},{"key":"2489_CR29","doi-asserted-by":"publisher","first-page":"515","DOI":"10.2147\/CEOR.S262772","volume":"12","author":"D Mladsi","year":"2020","unstructured":"Mladsi D, Barnett C, Aggarwal K, et al. Cost- Effectiveness of avatrombopag for the treatment of thrombocytopenia in patients with chronic liver disease. Clinicoecon Outcomes Res. 2020;12:515\u201326.","journal-title":"Clinicoecon Outcomes Res"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-026-02489-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00535-026-02489-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-026-02489-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T07:57:01Z","timestamp":1792828621000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00535-026-02489-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,30]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["2489"],"URL":"https:\/\/doi.org\/10.1007\/s00535-026-02489-z","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,30]]},"assertion":[{"value":"31 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Naoki Morimoto received lecture fees from AbbVie, Eisai, and Chugai; Satoru Kakizaki received lecture fees from AbbVie; Tadashi Ikegami received lecture fees from AbbVie and AstraZeneca; Kouichi Miura received a research grant from Gilead Sciences; Satoshi Mochida received a research grant from AbbVie GK, Eisai Co., Ltd., Sumitomo Parma Co., Ltd., and Intellim Corporation; Satoshi Mochida received lecture fees from AbbVie GK, Gilead Sciences Inc., ASKA Pharmaceutical Co., Ltd., AstraZeneca K. K., Otsuka Pharmaceutical Co., Ltd., Toray Medical Co., Ltd., Eisai Co., Ltd., and Chugai Pharmaceutical Co., Ltd; The other authors declare no conflicts of interest. Satoshi Mochida is the Director General of The Japanese Society of Gastroenterology.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}